Zhen Huang
Direttore/Membro del Consiglio presso WALVAX BIOTECHNOLOGY CO., LTD.
Patrimonio netto: 63 M $ in data 30/04/2024
Posizioni attive di Zhen Huang
Società | Posizione | Inizio | Fine |
---|---|---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | 22/08/2019 | - |
Corporate Officer/Principal | 01/01/2003 | 22/08/2019 | |
Yuxi Walvax Biotechnology Co., Ltd. | Presidente | - | - |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Zhen Huang
Statistiche
Distribuzione geografica
Cina | 4 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
President | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
Aziende private | 2 |
---|---|
Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Zhen Huang
- Esperienza